Ilyang Pharm (007570)

Currency in KRW
11,750
-80(-0.68%)
Closed·
007570 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11,58011,950
52 wk Range
10,78016,240
Key Statistics
Bid/Ask
11,730.00 / 11,750.00
Prev. Close
11,750
Open
11,830
Day's Range
11,580-11,950
52 wk Range
10,780-16,240
Volume
99.02K
Average Volume (3m)
158.7K
1-Year Change
4.7237%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
007570 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin-si, South Korea.

Employees
666

Compare 007570 to Peers and Sector

Metrics to compare
007570
Peers
Sector
Relationship
P/E Ratio
30.5x14.9x−0.5x
PEG Ratio
−1.300.140.00
Price/Book
0.9x0.9x2.6x
Price / LTM Sales
0.8x0.8x3.2x
Upside (Analyst Target)
-30.4%44.2%
Fair Value Upside
Unlock10.2%5.5%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 375.00%
Dividend Yield
1.31%
Industry Median 1.01%
Annualized payout
155.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Mar 11, 2026
EPS / Forecast
-269.48 / --
Revenue / Forecast
78.91B / --
EPS Revisions
Last 90 days

007570 Income Statement

People Also Watch

41,600
007340
+5.58%
31,200
108670
-0.95%
24,450
000240
-2.20%
5,680
028670
+3.84%
27,150
012630
-0.18%

FAQ

What Is the Ilyang Pharm (007570) Stock Price Today?

The Ilyang Pharm stock price today is 11,750 KRW.

What Stock Exchange Does Ilyang Pharm Trade On?

Ilyang Pharm is listed and trades on the Seoul Stock Exchange.

What Is the Stock Symbol for Ilyang Pharm?

The stock symbol for Ilyang Pharm is "007570."

Does Ilyang Pharm Pay Dividends? What’s The Current Dividend Yield?

The Ilyang Pharm dividend yield is 1.32%.

What Is the Ilyang Pharm Market Cap?

As of today, Ilyang Pharm market cap is 210.62B KRW.

What Is Ilyang Pharm's Earnings Per Share (TTM)?

The Ilyang Pharm EPS (TTM) is 375.

When Is the Next Ilyang Pharm Earnings Date?

Ilyang Pharm will release its next earnings report on Nov 12, 2025.

From a Technical Analysis Perspective, Is 007570 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Ilyang Pharm Stock Split?

Ilyang Pharm has split 5 times.

How Many Employees Does Ilyang Pharm Have?

Ilyang Pharm has 666 employees.

What is the current trading status of Ilyang Pharm (007570)?

As of Apr 20, 2026, Ilyang Pharm (007570) is trading at a price of 11,750 KRW, with a previous close of 11,750 KRW. The stock has fluctuated within a day range of 11,580 KRW to 11,950 KRW, while its 52-week range spans from 10,780 KRW to 16,240 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.